{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:33:56Z","timestamp":1784342036331,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003062","name":"Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016209","name":"Erciyes University Scientific Research Projects Coordination Unit","doi-asserted-by":"publisher","award":["TSA-2022-11344"],"award-info":[{"award-number":["TSA-2022-11344"]}],"id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.fct.2025.115235","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T17:13:00Z","timestamp":1735837980000},"page":"115235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: An experimental study"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-7948","authenticated-orcid":false,"given":"Menek\u015fe","family":"\u00dclger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7737-2553","authenticated-orcid":false,"given":"Birkan","family":"\u00dclger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-2207","authenticated-orcid":false,"given":"I\u015f\u0131l Tu\u011f\u00e7e","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2766-4312","authenticated-orcid":false,"given":"\u015eahin","family":"Temel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-8372","authenticated-orcid":false,"given":"Arzu","family":"Yay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-9403","authenticated-orcid":false,"given":"Bet\u00fcl","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5456-4579","authenticated-orcid":false,"given":"Birkan","family":"Yakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2025.115235_bib1","volume":"vol. 107","author":"Andrea","year":"2010"},{"issue":"7","key":"10.1016\/j.fct.2025.115235_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3899\/jrheum.101144","article-title":"Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies","volume":"38","author":"Airo","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.fct.2025.115235_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112292","article-title":"Models in vivo and in vitro for the study of acute and chronic inflammatory activity: a comprehensive review","volume":"135","author":"Bernardette Mart\u00ednez-Rizo","year":"2024","journal-title":"Int. Immunopharm."},{"issue":"4","key":"10.1016\/j.fct.2025.115235_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute lung injury: a clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"issue":"5","key":"10.1016\/j.fct.2025.115235_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3851\/IMP1729","article-title":"Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir","volume":"12","author":"Buys","year":"2011","journal-title":"Antivir. Chem. Chemother."},{"issue":"10","key":"10.1016\/j.fct.2025.115235_bib6","first-page":"1192","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","volume":"6","author":"Cai","year":"2020","journal-title":"Engineering (Beijing) Oct"},{"issue":"4","key":"10.1016\/j.fct.2025.115235_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002790","article-title":"Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever","volume":"10","author":"Caroline","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.fct.2025.115235_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S275595","article-title":"Reactive oxygen species: drivers of physiological and pathological processes","volume":"13","author":"Checa","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"4 Pt 1","key":"10.1016\/j.fct.2025.115235_bib9","first-page":"L159","article-title":"Pathobiology of pulmonary fibrosis","volume":"259","author":"Crouch","year":"1990","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.54817\/IC.v65n1a08","article-title":"Pulmonary toxicity associated with high-dose favipiravir and treatment options: biochemical and histopathological evaluation","volume":"65","author":"Elma","year":"2024","journal-title":"Invest. Clin."},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23536","article-title":"Assessment of toxicological effects of favipiravir (T-705) on the lung tissue of rats: an experimental study","volume":"38","author":"Erba\u015f","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0953-6205(00)00068-6","article-title":"Leukocyte activation and cytokine production during experimental human endotoxemia","volume":"11","author":"Fijen","year":"2000","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.fct.2025.115235_bib14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.fct.2025.115235_bib15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ki.1992.75","article-title":"The biology of the myofibroblast","volume":"41","author":"Gabbiani","year":"1992","journal-title":"Kidney Int. Mar"},{"issue":"3","key":"10.1016\/j.fct.2025.115235_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/a-1296-7935","article-title":"Favipiravir and COVID-19: a simplified summary","volume":"71","author":"Ghasemnejad-Berenji","year":"2021","journal-title":"Drug Res."},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2009.10.015","article-title":"Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models","volume":"86","author":"Gowen","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.fct.2025.115235_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2022.09.011","article-title":"Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells","volume":"371","author":"Gunaydin-Akyildiz","year":"2022","journal-title":"Toxicol. Lett."},{"issue":"8","key":"10.1016\/j.fct.2025.115235_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/14787210.2021.1866545","article-title":"A review on favipiravir: the properties, function, and usefulness to treat COVID-19","volume":"19","author":"Hashemian","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.fct.2025.115235_bib20","unstructured":"Information provided by Dr. Reddy's Laboratories Limited. Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients. Responsible. s.l. : National library of medicine. Mar. https:\/\/beta.clinicaltrials.gov\/study\/NCT04529499?tab=results."},{"issue":"6","key":"10.1016\/j.fct.2025.115235_bib21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/aps.2016.36","article-title":"Paeoniflorin suppresses TGF-\u03b2 mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway","volume":"37","author":"Ji","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"43","key":"10.1016\/j.fct.2025.115235_bib22","doi-asserted-by":"crossref","first-page":"26955","DOI":"10.1073\/pnas.2014441117","article-title":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity","volume":"27","author":"Kaptein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.fct.2025.115235_bib23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/01480545.2022.2066116","article-title":"Evaluation of the toxicological effects of favipiravir (T-705) on liver and kidney in rats: biochemical and histopathological approach","volume":"46","author":"Kara","year":"2023","journal-title":"Drug Chem. Toxicol."},{"issue":"35","key":"10.1016\/j.fct.2025.115235_bib24","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"29","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5152\/eajm.2013.08","article-title":"Tissue damage and oxidant\/antioxidant balance","volume":"45","author":"Kisaoglu","year":"2013","journal-title":"Eurasian J MedFeb"},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/jcm10020273","article-title":"Favipiravir in therapy of viral infections","volume":"13","author":"\u0141agocka","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1\u20133","key":"10.1016\/j.fct.2025.115235_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0300-483X(00)00437-6","article-title":"Role of macrophages and inflammatory mediators in chemically induced toxicity","volume":"7","author":"Laskin","year":"2001","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1134\/S0022093022020119","article-title":"Evaluation of the effects of favipiravir combined with vitamin C on alveolar bone in rats","volume":"58","author":"Lektemur Alpan","year":"2022","journal-title":"J. Evol. Biochem. Physiol."},{"issue":"8","key":"10.1016\/j.fct.2025.115235_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40262-015-0364-1","article-title":"Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials","volume":"55","author":"Madelain","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12879-021-06164-x","article-title":"Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis","volume":"21","author":"Manabe","year":"2021","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/cyto.1999.0517","article-title":"Interleukin 8 production in whole blood assays: is interleukin 10 responsible for the downregulation observed in sepsis?","volume":"12","author":"Marie","year":"2000","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib32","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","article-title":"Murine models of pulmonary fibrosis","volume":"294","author":"Moore","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol Feb."},{"issue":"9","key":"10.1016\/j.fct.2025.115235_bib33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nm1091","article-title":"Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity","volume":"10","author":"Moyron-Quiroz","year":"2004","journal-title":"Nat. Med."},{"issue":"4 Suppl. l","key":"10.1016\/j.fct.2025.115235_bib34","doi-asserted-by":"crossref","first-page":"N3","DOI":"10.1097\/00003246-200004001-00002","article-title":"Cytokine signaling--regulation of the immune response in normal and critically ill states","volume":"28","author":"Oberholzer","year":"2000","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.fct.2025.115235_bib35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V90.4.1415","article-title":"Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans","volume":"15","author":"Pajkrt","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12931-018-0935-4","article-title":"Inflammation and lung injury in an ovine model of fluid resuscitated endotoxemic shock","volume":"22","author":"Passmore","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.fct.2025.115235_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-381300-8.00007-1","article-title":"Bronchus-associated lymphoid tissue (BALT) structure and function","volume":"107","author":"Randall","year":"2010","journal-title":"Adv. Immunol."},{"issue":"12","key":"10.1016\/j.fct.2025.115235_bib38","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1172\/JCI28756","article-title":"Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis","volume":"116","author":"Rangel-Moreno","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.fct.2025.115235_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2014.01.016","article-title":"Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment","volume":"104","author":"Scharton","year":"2014","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"16","author":"Selman","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.fct.2025.115235_bib41","doi-asserted-by":"crossref","first-page":"L562","DOI":"10.1152\/ajplung.2000.279.3.L562","article-title":"TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?","volume":"279","author":"Selman","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.fct.2025.115235_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.fct.2025.115235_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.fct.2025.115235_bib44","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.etap.2015.02.019","article-title":"The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice","volume":"39","author":"Sohn","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2012.03.001","article-title":"Combinations of favipiravir and peramivir for the treatment of pandemic influenza A\/California\/04\/2009 (H1N1) virus infections in mice","volume":"94","author":"Tarbet","year":"2012","journal-title":"Antiviral Res. Apr."},{"key":"10.1016\/j.fct.2025.115235_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2021.101958","article-title":"The effect of erythropoietin and umbilical cord-derived mesenchymal stem cells on nerve regeneration in rats with sciatic nerve injury","volume":"114","author":"\u00dclger","year":"2021","journal-title":"J. Chem. Neuroanat."},{"issue":"11","key":"10.1016\/j.fct.2025.115235_bib47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China","volume":"17","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.fct.2025.115235_bib48","doi-asserted-by":"crossref","first-page":"L525","DOI":"10.1152\/ajplung.00163.2007","article-title":"TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease","volume":"293","author":"Willis","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.fct.2025.115235_bib50","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","article-title":"Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis","volume":"304","author":"Zeisberg","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.fct.2025.115235_bib51","first-page":"114","article-title":"Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study","volume":"145","author":"Zhang","year":"1994","journal-title":"Am. J. Pathol. Jul"},{"issue":"33","key":"10.1016\/j.fct.2025.115235_bib52","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.2174\/0929867326666190620103813","article-title":"Bioactivities of natural catalpol derivatives","volume":"26","author":"Zhang","year":"2019","journal-title":"Curr. Med. Chem."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691525000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691525000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T22:41:03Z","timestamp":1748904063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691525000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":51,"alternative-id":["S0278691525000018"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2025.115235","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the effects of favipiravir (T-705) on the lung tissue of healty rats: An experimental study","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2025.115235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115235"}}